Innovative trial design may have cost Lilly's accelerated Alzheimer's approval
Novartis CEO says Covid likely to become endemic, urges investment in pandemic preparedness
Cyteir lays off 70% of workforce after further narrowing cancer drug goals
Astellas, after years of gene therapy woes, gets rare boost with FDA lifting of Pompe clinical hold
*please scroll down for all the latest news*
